Letter to the Editor: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR
Author:
Open Access
- 1 January 2020
- journal article
- letter
- Published by XMLink in Journal of Korean Medical Science
- Vol. 35 (7) , e88
Abstract
Kim JY. J Korean Med Sci. 2019 Dec;35(7):e88. https://doi.org/10.3346/jkms.2020.35.e88Keywords
This publication has 5 references indexed in Scilit:
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitroCell Research, 2020
- Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCRJournal of Korean Medical Science, 2020
- The First Case of 2019 Novel Coronavirus Pneumonia Imported into Korea from Wuhan, China: Implication for Infection Prevention and Control MeasuresJournal of Korean Medical Science, 2020
- Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findingsThorax, 2004
- Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study.2003